| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $504,409 ) |
| | 2025 | 2025 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | | | | AUS | R01AI172823 | Regulation of latent stage differentiation through central carbon metabolism and ubiquitination | 000 | 3 | NIH | 12/20/2024 | $504,409 |
|
| Issue Date FY: 2024 ( Subtotal = $1,182,944 ) |
| | 2024 | 2024 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | | | | AUS | R01AI172823 | Regulation of latent stage differentiation through central carbon metabolism and ubiquitination | 001 | 2 | NIH | 4/15/2024 | $52,002 |
| | 2024 | 2024 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | | | | AUS | U19AI129392 | Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region | 000 | 9 | NIH | 6/6/2024 | $662,935 |
| | 2024 | 2024 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | R01AI172823 | Regulation of latent stage differentiation through central carbon metabolism and ubiquitination | 000 | 2 | NIH | 12/7/2023 | $468,007 |
|
| Issue Date FY: 2023 ( Subtotal = $1,150,047 ) |
| | 2023 | 2023 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | U19AI129392 | Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region | 002 | 8 | NIH | 8/24/2023 | $0 |
| | 2023 | 2023 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | R01AI172823 | Regulation of latent stage differentiation through central carbon metabolism and ubiquitination | 001 | 1 | NIH | 9/21/2023 | $104,402 |
| | 2023 | 2023 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | R01AI172823 | Regulation of latent stage differentiation through central carbon metabolism and ubiquitination | 000 | 1 | NIH | 12/2/2022 | $417,608 |
| | 2023 | 2023 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | U19AI129392 | Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region | 001 | 8 | NIH | 3/28/2023 | $628,037 |
| | 2023 | 2022 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | U19AI129392 | Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region | 000 | 7 | NIH | 1/23/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $622,381 ) |
| | 2022 | 2022 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | U19AI129392 | Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region | 000 | 7 | NIH | 4/12/2022 | $622,381 |
|
| Issue Date FY: 2021 ( Subtotal = $1,183,969 ) |
| | 2021 | 2021 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | U19AI129392 | Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region | 002 | 6 | NIH | 5/18/2021 | $622,427 |
| | 2021 | 2020 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | U19AI129392 | Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region | 001 | 5 | NIH | 3/18/2021 | $345,824 |
| | 2021 | 2020 | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE | VIC | | | AUS | U19AI129392 | Understanding and Targeting the Barriers to Effective Malaria Control and Elimination in the Asia-Pacific Region | 004 | 5 | NIH | 9/24/2021 | $215,718 |
|
| Issue Date FY: 2014 ( Subtotal = $223,296 ) |
| | 2014 | 2014 | WALTER & ELIZA HALL INSTITUTE OF MEDICAL RESEARCH | 1G ROYAL PDE | PARKVILLE VICTORIA | | | | AUS | R37CA022556 | Differentiation of Granulocytes and Macrophages | 000 | 36 | NIH | 7/29/2014 | $223,296 |
|
| Issue Date FY: 2013 ( Subtotal = $216,389 ) |
| | 2013 | 2013 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | | | AUS | R37CA022556 | Differentiation of Granulocytes and Macrophages | 000 | 35 | NIH | 7/30/2013 | $216,389 |
|
| Issue Date FY: 2012 ( Subtotal = $230,201 ) |
| | 2012 | 2012 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | | | AUS | R37CA022556 | Differentiation of Granulocytes and Macrophages | 000 | 34 | NIH | 7/27/2012 | $230,201 |
|
| Issue Date FY: 2011 ( Subtotal = $230,201 ) |
| | 2011 | 2011 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | | | AUS | R37CA022556 | Differentiation of Granulocytes and Macrophages | 000 | 33 | NIH | 7/22/2011 | $230,201 |
|
| Issue Date FY: 2010 ( Subtotal = $237,320 ) |
| | 2010 | 2010 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | | | AUS | R37CA022556 | Differentiation of Granulocytes and Macrophages | 000 | 32 | NIH | 6/14/2010 | $237,320 |
|
| Issue Date FY: 2009 ( Subtotal = $788,929 ) |
| | 2009 | 2009 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | - | | AUS | R01AI044008 | ADHERENCE OF MALARIA-INFECTED RED CELLS | 001 | 11 | NIH | 6/26/2009 | $20,092 |
| | 2009 | 2009 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | - | | AUS | R01AI044008 | ADHERENCE OF MALARIA-INFECTED RED CELLS | 000 | 11 | NIH | 2/19/2009 | $180,824 |
| | 2009 | 2009 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | - | | AUS | R01CA043540 | ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICE | 000 | 22 | NIH | 3/25/2009 | $174,086 |
| | 2009 | 2009 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | - | | AUS | R01HL080019 | GENOMIC DISSECTION OF PLATELET PRODUCTION | 000 | 4 | NIH | 6/29/2009 | $183,519 |
| | 2009 | 2009 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | - | | AUS | R37CA022556 | Differentiation of Granulocytes and Macrophages | 000 | 31 | NIH | 7/8/2009 | $230,408 |
| | 2009 | 2008 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01DK062882 | IDENTIFICATION OF MOUSE DIABETES SUSCEPTIBILITY GENES | 000 | 4 | NIH | 6/18/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $1,199,486 ) |
| | 2008 | 2008 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01DK062882 | IDENTIFICATION OF MOUSE DIABETES SUSCEPTIBILITY GENES | 000 | 4 | NIH | 5/22/2008 | $154,548 |
| | 2008 | 2008 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01HL079545 | CONGENITAL MYELOID FAILURE SYNDROMES | 000 | 6 | NIH | 7/15/2008 | $256,009 |
| | 2008 | 2008 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01HL080019 | GENOMIC DISSECTION OF PLATELET PRODUCTION | 000 | 3 | NIH | 6/26/2008 | $183,519 |
| | 2008 | 2008 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R37CA022556 | Differentiation of Granulocytes and Macrophages | 000 | 30 | NIH | 7/24/2008 | $230,408 |
| | 2008 | 2008 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01CA043540 | ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICE | 000 | 21 | NIH | 4/18/2008 | $174,086 |
| | 2008 | 2008 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01AI044008 | ADHERENCE OF MALARIA-INFECTED RED CELLS | 000 | 10 | NIH | 2/7/2008 | $200,916 |
|
| Issue Date FY: 2007 ( Subtotal = $1,305,092 ) (Continued on the next page) |
| | 2007 | 2007 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01HL080019 | GENOMIC DISSECTION OF PLATELET PRODUCTION | 000 | 2 | NIH | 7/5/2007 | $235,953 |
| | 2007 | 2007 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | F33AI077118 | PHOSPHOMANNOMUTASE (PMM) AS A NOVEL DRUG TARGET FOR THE PARASITE LEISHMANIA | 000 | 1 | NIH | 6/21/2007 | $38,277 |
| | 2007 | 2007 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | F33AI077118 | PHOSPHOMANNOMUTASE (PMM) AS A NOVEL DRUG TARGET FOR THE PARASITE LEISHMANIA | 001 | 1 | NIH | 9/11/2007 | $7,850 |
| | 2007 | 2007 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01AI044008 | ADHERENCE OF MALARIA-INFECTED RED CELLS | 000 | 9 | NIH | 3/7/2007 | $204,807 |
| | 2007 | 2007 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01CA043540 | ONCOGENE INDUCED LEUKEMOGENESIS IN TRANGENIC MICE | 000 | 20 | NIH | 4/24/2007 | $174,086 |
| | 2007 | 2007 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R37CA022556 | Differentiation of Granulocytes and Macrophages | 000 | 29 | NIH | 7/12/2007 | $230,408 |
| | 2007 | 2007 | WALTER & ELIZA HALL INSTITUTION OF MEDICINE | ROYAL MELBOURNE HOSPITAL | MELBOURNE | | 00000 | | AUS | R01HL079545 | CONGENITAL MYELOID FAILURE SYNDROMES | 000 | 5 | NIH | 7/24/2007 | $256,009 |
|
